ABOBOTULINUMTOXINA: 5,789 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
5,789
Total FAERS Reports
109 (1.9%)
Deaths Reported
406
Hospitalizations
5,789
As Primary/Secondary Suspect
47
Life-Threatening
146
Disabilities
Prescription
Status
FDA Application: 125274 ·
First Report: 19990311 · Latest Report: 20250905
What Are the Most Common ABOBOTULINUMTOXINA Side Effects?
#1 Most Reported
Off label use
2,271 reports (39.2%)
#2 Most Reported
Drug ineffective
1,677 reports (29.0%)
#3 Most Reported
Product preparation error
751 reports (13.0%)
All ABOBOTULINUMTOXINA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,271 | 39.2% | 29 | 115 |
| Drug ineffective | 1,677 | 29.0% | 0 | 5 |
| Product preparation error | 751 | 13.0% | 2 | 9 |
| Headache | 379 | 6.6% | 1 | 37 |
| Overdose | 344 | 5.9% | 2 | 16 |
| Inappropriate schedule of drug administration | 318 | 5.5% | 1 | 8 |
| Therapeutic response shortened | 313 | 5.4% | 0 | 1 |
| Eyelid ptosis | 301 | 5.2% | 1 | 29 |
| Injection site pain | 278 | 4.8% | 0 | 4 |
| Muscular weakness | 272 | 4.7% | 2 | 63 |
| Intentional product misuse | 259 | 4.5% | 0 | 4 |
| Dysphagia | 240 | 4.2% | 5 | 84 |
| Vision blurred | 234 | 4.0% | 1 | 30 |
| Dyspnoea | 194 | 3.4% | 3 | 66 |
| Dizziness | 193 | 3.3% | 0 | 34 |
| Wrong technique in product usage process | 186 | 3.2% | 0 | 4 |
| Fatigue | 183 | 3.2% | 1 | 38 |
| Pain | 175 | 3.0% | 0 | 16 |
| Nausea | 174 | 3.0% | 0 | 31 |
| Asthenia | 167 | 2.9% | 1 | 51 |
Who Reports ABOBOTULINUMTOXINA Side Effects? Age & Gender Data
Gender: 87.3% female, 12.7% male. Average age: 46.6 years. Most reports from: US. View detailed demographics →
Is ABOBOTULINUMTOXINA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 2 | 0 | 0 |
| 2003 | 1 | 0 | 0 |
| 2004 | 3 | 0 | 0 |
| 2006 | 1 | 0 | 0 |
| 2007 | 1 | 0 | 0 |
| 2008 | 2 | 0 | 1 |
| 2009 | 7 | 0 | 3 |
| 2010 | 3 | 0 | 2 |
| 2011 | 22 | 0 | 1 |
| 2012 | 25 | 3 | 4 |
| 2013 | 14 | 1 | 3 |
| 2014 | 81 | 3 | 18 |
| 2015 | 140 | 7 | 31 |
| 2016 | 243 | 8 | 29 |
| 2017 | 304 | 6 | 26 |
| 2018 | 385 | 7 | 45 |
| 2019 | 268 | 6 | 24 |
| 2020 | 204 | 5 | 19 |
| 2021 | 338 | 11 | 26 |
| 2022 | 434 | 8 | 19 |
| 2023 | 469 | 4 | 31 |
| 2024 | 252 | 7 | 19 |
| 2025 | 112 | 3 | 22 |
What Is ABOBOTULINUMTOXINA Used For?
| Indication | Reports |
|---|---|
| Skin wrinkling | 2,890 |
| Off label use | 2,170 |
| Skin cosmetic procedure | 1,291 |
| Muscle spasticity | 595 |
| Product used for unknown indication | 419 |
| Product use in unapproved indication | 334 |
| Torticollis | 320 |
| Product use issue | 88 |
| Hemiplegia | 53 |
| Dystonia | 48 |
ABOBOTULINUMTOXINA vs Alternatives: Which Is Safer?
ABOBOTULINUMTOXINA vs ABRAXANE
ABOBOTULINUMTOXINA vs ABROCITINIB
ABOBOTULINUMTOXINA vs ACALABRUTINIB
ABOBOTULINUMTOXINA vs ACAMPROSATE
ABOBOTULINUMTOXINA vs ACARBOSE
ABOBOTULINUMTOXINA vs ACCUTANE
ABOBOTULINUMTOXINA vs ACEBUTOLOL
ABOBOTULINUMTOXINA vs ACECLOFENAC
ABOBOTULINUMTOXINA vs ACEMETACIN
ABOBOTULINUMTOXINA vs ACENOCOUMAROL
Official FDA Label for ABOBOTULINUMTOXINA
Official prescribing information from the FDA-approved drug label.